Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
Clinical trial NCT04478123 · COMPLETED
Trial details
- NCT number
- NCT04478123
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2023-06-08
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.